Skip to main content

Table 2 Characteristics of patients with suspected myocarditis and controls

From: A novel multiparametric imaging approach to acute myocarditis using T2-mapping and CMR feature tracking

Parameter Controls Myocarditis patients p-value
Number 17 67 n.a.
Females / Males 6/11 18/49 n.a.
Age [years] 36 ± 12 37 ± 14 .849
Height [cm] 178 ± 11 177 ± 9 .788
Weight [kg] 77 ± 14 79 ± 14 .671
Heart rate [bpm] 63 ± 15 65 ± 13 .743
Symptom duration before CMR [days] n.a. 4.8 ± 4.4 n.a.
Initial TnT [μg/l] n.a. 3.0 ± 16.1 n.a.
Initial NT-proBNP [pg/ml] n.a. 2380 ± 5535 n.a.
Initial CK [U/l] n.a. 2942 ± 1719 n.a.
Initial CRP [mg/l] n.a. 37.4 ± 43.5 n.a.
LVa EDb volume / BSAc [ml/m2] 81 ± 14 84 ± 21 .486
LV ESd volume / BSA [ml/m2] 29 ± 8 33 ± 10 .081
LV ejection fraction [%] 65 ± 5 62 ± 7 .032
LV ED wall mass / BSA [g/m2] (without papillary muscles) 47 ± 11 54 ± 15 .026
T2-Ratio 1.8 ± 1.4 2.2 ± 0.9 .097
≥ 2 out of 3 LLCe [%] 0 57 n.a.
1 out of 3 LLC [%] 24 27 n.a.
0 out of 3 LLC [%] 76 16 n.a.
  1. a LV left ventricle, b ED end diastolic, c BSA body surface area, d ES end systolic, e LLC Lake Louise criteria
  2. Statistical significant p values are printed in bold face